Populated franchise territories currently for sale in Aust & NZ

Learn more

TDDA logo
Health Tick Logo

1300 4 DETECTION (1300 4 33 832)

0508 DRUGTEST (0508 3784 8378)

enquire now
  • Drug Testing Services
    • Overview
    • Urine
    • Alcohol
    • Oral Fluid
    • Hair
    • Synthetic
    • Meth
    • Privacy Statement
  • Imperans
  • Background Checks
  • Training
  • Drug Policy Design
  • News
  • About
    • Who We Are
    • Our Leadership
    • Franchises
    • Privacy Statement
  • Contact

AUSTRALIA 1300 4 DETECTION (1300 4 33 832)

NEW ZEALAND 0508 DRUGTEST (0508 3784 8378)

TDDA logo
Health Tick Logo
  • Drug Testing Services
    • Overview
    • Urine
    • Alcohol
    • Oral Fluid
    • Hair
    • Synthetic
    • Meth
    • Privacy Statement
  • Imperans
  • Background Checks
  • Training
  • Drug Policy Design
  • News
  • About
    • Who We Are
    • Our Leadership
    • Franchises
    • Privacy Statement
  • Contact

Glenn Dobson on Newstalk ZB – Drive with Heather du Plessis-Allan

by Maree Boyd | May 19, 2025 | TDDA in the news

Glenn Dobson was invited to speak on radio to Heather du Plessis-Allan “NewstalkZB Drive” to discuss new TDDA New Zealand data that shows methamphetamine (meth) detection is growing and making up a disproportionate share of non-negative workplace drug test results....

TDDA continues to lead the way with drug testing innovation as featured in the DEMM Engineering & Manufacturing publication – “TDDA adds Tramadol and Fentanyl testing”

https://demm.co.nz/article/tdda-adds-tramadol-and-fentanyl-testing

Imperans Q4 Report, State of Workplace Drug Use from TDDA

by Maree Boyd | Feb 28, 2025 | TDDA media releases

Recent data indicates an increase in amphetamine-type substances and opioids AUCKLAND, New Zealand, 25 February 2024 – The Drug Detection Agency (TDDA), New Zealand’s largest workplace drug testing provider has released its Q4 2024 workplace drug and alcohol...
COMING SOON – 2 new drug types added to TDDA drug screening devices

COMING SOON – 2 new drug types added to TDDA drug screening devices

by Maree Boyd | Feb 21, 2025 | Content by TDDA

TDDA are proud to announce the soon to be released updated TDDA branded oral fluid and urine screening devices that includes the option of 2 extra drug types “Tramadol & Fentanyl”. The development of these new screening devices is part of TDDA’s ongoing commitment...

Opinion Piece: Time to Reevaluate the Medicinal Cannabis Framework

by Maree Boyd | Jan 21, 2025 | Content by TDDA

By Glenn Dobson, CEO of The Drug Detection Agency (TDDA) The rapid expansion of the medicinal cannabis market in Australia and New Zealand raises significant concerns about workplace safety and public health. As someone deeply committed to maintaining drug-free and...
« Older Entries
Next Entries »

Recent Posts

  • Australia – Imperans Q4 Report, State of Workplace Drug Use from TDDA
  • New Zealand – Imperans Q4 Report, State of Workplace Drug Use from TDDA
  • Health and Safety Policy Survey
  • Roadside Drug Testing vs Workplace Drug Testing: Same Safety Goal, But Confusing Them Is a Risk in Itself
  • “Workplace Drug Use Rising” – Ticker News interview with Glenn Dobson

Recent Comments

No comments to show.
TDDA logo

Contact us

NEW ZEALAND
0508 DRUGTEST (0508 3784 8378)
AUSTRALIA
1300 4 DETECTION (1300 4 33 832)

Find your local tdda office

© TDDA 2026 • Privacy and Data Protection Statement • Website designed by Husk
  • Follow
  • Follow